ArticlePloS one2014
Genital human papillomavirus infection among women in Bangladesh: findings from a population-based survey.
Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and Type Distribution of Human Papillomavirus Recovered from the Uterine Cervix of Nigerian Women: A Systematic Review and Meta-AnalysisAsian Pacific journal of cancer prevention : APJCP · 2020Pooled it
- Trial
- Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women.Sexually transmitted diseases · 2019Trial
- Human papillomavirus vaccination status among the urban and rural married women of Bangladesh: An analytical cross-sectional study.Preventive medicine reports · 2026Article
- Post translational modifications as biomarkers of soil microbe responses to nano-pesticides.Journal of nanobiotechnology · 2026Review
- Cervical Cancer, HPV, and HPV Vaccine Knowledge and Willingness to be Vaccinated Among Adolescent Girls in Dhaka, Bangladesh: A Cross-Sectional Study.Health science reports · 2026Article
- Prevalence of CMV, EBV, HPV, and HSV among South Asian healthy population: A systematic review and meta-analysis.PLOS global public health · 2026Article
- The effect of hrHPV prevalence on cervical cancer screening strategies: a cost-effectiveness study of Bangladesh.BMC public health · 2025Article
- High-risk human papillomavirus genotypes among women of hill districts in Bangladesh.PloS one · 2025Article
- Factors related to cervical cancer and human papilloma virus awareness among rural women of southern Bangladesh: A cross-sectional study.Gynecologic oncology reports · 2024Article
- Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, Ethiopia.Scientific reports · 2024Article
- Article
- Prevalence of human papillomavirus types associated with cervical lesions in Sergipe state, Northeastern Brazil: high frequency of a possibly carcinogenic type.Epidemiology and infection · 2018Article
- Ethical issues related to human papillomavirus vaccination programs: an example from Bangladesh.BMC medical ethics · 2018Review
- Knowledge of cervical cancer and HPV vaccine in Bangladeshi women: a population based, cross-sectional study.BMC women's health · 2018Article
- Knowledge and Acceptance of Human Papillomavirus Vaccine for Cervical Cancer Prevention Among Urban Professional Women in Bangladesh: A Mixed Method Study.BioResearch open access · 2018Article
- Histopathology of Cervical Cancer and Arsenic Concentration in Well Water: An Ecological Analysis.International journal of environmental research and public health · 2017Article
- A population-based study of cervical cytology findings and human papillomavirus infection in a suburban area of Thailand.Gynecologic oncology reports · 2017Article
- Community-Based Prevalence of Genital Human Papilloma Virus (HPV) Infection: a Systematic Review and Meta-AnalysisAsian Pacific journal of cancer prevention : APJCP · 2017Article
- Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.Medical microbiology and immunology · 2016Article
Corrections and comments
- Erratum issued
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere has been no population-based study on human papillomavirus (HPV) prevalence or its genotypes in Bangladesh; a country eligible for GAVI funding for HPV vaccine.
methodsWe used baseline survey data of a prospective cohort study that was conducted in one urban and one rural area of Bangladesh. A total of 997 urban and 905 rural married women, aged 13 to 64 years, were enrolled in the baseline during July-December, 2011. Information was collected on socio-demographic characteristics and potential risk factors for HPV infection followed by gynecological examination and collection of endocervical samples using the cervical cytobrush (Digene cervical sampler). HPV DNA testing was done by Polymerase Chain Reaction (PCR) using a consensus primer set.
resultsPrevalence of any HPV infection was 7.7% with no significant difference between urban and rural women. Most common high-risk genotypes were HPV16, HPV66, HPV18, HPV45, HPV31 and HPV53. Urban women working as housemaids or garment workers were at higher risk of any HPV infection (OR = 2.15, 95% CI: 1.13-4.11) compared to housewives. Rural women whose husband lived overseas were almost two times more likely to have any HPV infection (OR = 1.93; 95% CI 1.05-3.55) compared to women whose husbands lived with them.
conclusionThe prevalence of HPV infection among Bangladeshi women is similar to other regions of Asia. However, type-specific patterns are different. The study findings will inform the formulation of HPV vaccination policies in Bangladesh, monitoring the impact of vaccination programmes, and the identification of target populations for screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.